These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1378245)

  • 1. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
    Nielsen JB; Bertelsen A; Lou HC
    Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF and urine biogenic amine metabolites in Rett syndrome.
    Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B
    Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
    Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
    Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usual values for 5-hydroxy-indol acetic acid and homovanillic acid in cerebrospinal fluid].
    Dhondt JL; Forzy G
    Ann Biol Clin (Paris); 2003; 61(1):69-75. PubMed ID: 12604388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
    Pranzatelli MR; Huang YY; Tate E; Goldstein DS; Holmes CS; Goldstein EM; Ketner K; Kinast M; Lange BM; Sanz A; Shevell MI; Stanford RE; Taff IP
    Mov Disord; 1998 May; 13(3):522-8. PubMed ID: 9613746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
    Matsuishi T; Nagamitsu S; Yamashita Y; Murakami Y; Kimura A; Sakai T; Shoji H; Kato H; Percy AK
    Ann Neurol; 1997 Dec; 42(6):978-81. PubMed ID: 9403492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR
    Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolites of neurotransmitters in the cerebrospinal fluid in children].
    Zeman J; Böswart J
    Cesk Pediatr; 1991 May; 46(5):262-5. PubMed ID: 1716526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and clinical effects of tyrosine and tryptophan in the Rett syndrome.
    Nielsen JB; Lou HC; Andresen J
    Brain Dev; 1990; 12(1):143-7. PubMed ID: 1693042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
    Zeman J; Böswart J
    Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
    Nishijima K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome.
    Ramaekers VT; Sequeira JM; Artuch R; Blau N; Temudo T; Ormazabal A; Pineda M; Aracil A; Roelens F; Laccone F; Quadros EV
    Neuropediatrics; 2007 Aug; 38(4):179-83. PubMed ID: 18058624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.